[Anticoagulants].
作者信息
Coelho E
出版信息
Rev Hosp Clin Fac Med Sao Paulo. 1968 Jul;23(4):217-28.
PMID:4175980
Abstract
摘要
相似文献
1
[Anticoagulants].[抗凝剂]
Rev Hosp Clin Fac Med Sao Paulo. 1968 Jul;23(4):217-28.
2
[Treatment of thromboembolic conditions with thrombolytics and anticoagulants].[使用溶栓剂和抗凝剂治疗血栓栓塞性疾病]
Wiad Lek. 1974 May 15;27(10):877-82.
3
The management of adequate anticoagulant therapy and its complications.
Vasc Dis. 1966 Oct;3(5):295-304.
4
5
[Anticoagulants. 43].[抗凝剂。43]。
Pharm Prax. 1969 Dec;12:279-87.
6
[On the treatment of myocardial infarct with special reference to fibrinolytic substances].[关于心肌梗死的治疗，特别提及纤维蛋白溶解物质]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1969;92(1):38-45.
7
[Recent developments in the field of fibrinolytics and anticoagulants].[纤维蛋白溶解剂和抗凝剂领域的最新进展]
Internist (Berl). 1984 Feb;25(2):82-7.
8
[Hypercoagulation and cancer. New treatment possibilities].[高凝状态与癌症。新的治疗可能性]
Ugeskr Laeger. 2004 Aug 9;166(33):2781-4.
9
Disseminated intravascular coagulation. Heparin, anticoagulant and urokinase in experimental nephritic in mice.弥散性血管内凝血。肝素、抗凝剂及尿激酶在小鼠实验性肾炎中的应用。
Proc R Soc Med. 1968 Nov;61(11 Part 1):1137-8. doi: 10.1177/003591576806111P133.
10
[Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].[低分子量肝素——依诺肝素（克赛）在预防外科手术患者血栓栓塞并发症中的应用]
Anesteziol Reanimatol. 2001 Mar-Apr(2):70-5.
Zotero 插件